DIFFERENCE IN THE BLOOD MONOCYTE PHENOTYPE BETWEEN UREMIC PATIENTS AND HEALTHY CONTROLS - ITS RELATION TO MONOCYTE DIFFERENTIATION INTO MACROPHAGES IN THE PERITONEAL-CAVITY
A. Brauner et al., DIFFERENCE IN THE BLOOD MONOCYTE PHENOTYPE BETWEEN UREMIC PATIENTS AND HEALTHY CONTROLS - ITS RELATION TO MONOCYTE DIFFERENTIATION INTO MACROPHAGES IN THE PERITONEAL-CAVITY, Inflammation, 22(1), 1998, pp. 55-66
The phenotypic alterations between blood monocytes from 11 patients wi
th end-stage renal disease, who had been on peritoneal dialysis for le
ss than one week, and blood monocytes from 10 healthy controls, were a
nalyzed. In addition, peritoneal macrophages in the dialysate effluent
were enclosed. Analysis of functional receptor density was performed
using immunostaining and flow cytometry. The phenotypic characterizati
on was selected to represent various biological functions such as adhe
sion, phagocytosis (CD11b/CD18, CD11c/CD18, CD16), antigen-presentatio
n (HLA-DR, ICAM-1), differentiation (transferrin receptor, CD71), rece
ptor for LPS (CD14) and initiation of the coagulation cascade (Tissue
factor, CD142). The proportion of CD16-positive blood monocytes and th
e quantitative level of ICAM-1 were higher in the patient group, compa
red to healthy controls. A significant increase in the quantitative le
vel of CD11b/CD18, CD11c/CD18, HLA-DR and ICAM-1, transferrin receptor
, CD14 and CD16, was found on peritoneal macrophages, compared to mono
cytes, harvested both from the corresponding patients, as well as from
healthy donors. In contrast, we did not find any significant differen
ces in the expression of tissue factor between monocytes and peritonea
l macrophages. In conclusion, phenotypic differences exist between mon
ocyte populations in the blood circulation of CAPD patients, and healt
hy individuals. We also show that transmigration of monocytes into the
peritoneal cavity implies a selective up-regulation of functional rec
eptors, preferentially related to adhesion, and antigen-presentation i
n a steady-state situation in non-infected CAPD patients.